AllisonMw(Wahl)MalloyMD(She/Her)

Head of the Laboratory of Infectious Diseases and Host Defense, Associate Professor Department of Pediatrics, USUHS

Dr. Malloy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Vaccine Research Center, NIHClinical Research Fellowship, Respiratory viral immunology, 2011 - 2013
Children's National Hospital/George Washington UniversityFellowship, Pediatric Infectious Diseases, 2008 - 2011
Children's Hospital of PhiladelphiaResidency, Pediatrics, 2005 - 2008
George Washington University School of Medicine and Health SciencesClass of 2005

PubMed

14 citations
Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.
Belinda M. Jackson-Thompson, Emilie Goguet, Eric D Laing, Cara H. Olsen, Simon Pollett
BMC Infectious Diseases. 2021-12-01
35 citations
Extended-spectrum beta-lactamases: a brief clinical update.
Allison M. W. Malloy, Joseph M. Campos
The Pediatric Infectious Disease Journal. 2011-12-01
38 citations
SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses.
Joshua M Carmen, Shikha Shrivastava, Zhongyan Lu, Alexander Anderson, Elaine B Morrison
NPJ Vaccines. 2021-12-13